Introductory rate of $345 expires 3/24/10. Save $70 off the regular rate of $415. Click the sample link below to view the complete table of contents and select pages.

CNS/Neurology represents one of the two-largest therapeutic areas in the industry in terms products sales as well as the number of compounds in clinical development. The latter element is a very significant factor considering that many of the blockbuster medicines from the past decade for CNS and neurology have lost patent protection or are nearing the loss of their market exclusivity. CNS disorders are the most significant disease burden in high-income countries and is expected to substantially grow in other regions, including Asia, as the standard of living increases.


The following information is included in this special report, which details the leading disease/medical-use areas within the central nervous system and neurology categories:
Primary CNS/Neurology areas covered include Alzheimer’s disease, major depression disorder,
schizophrenia, Parkinson’s disease, epilepsy/seizures, migraine, insomnia/sleep disorders, bipolar disorder, and ADHD. For these areas as well as others, various charts and analysis of the current market leaders and anticipated future growth drivers are provided.
Prescription-drug pipeline covering various CNS/Neurology indications, detailing the following for each product:

• Each pipeline products’ chemical or substance composition, intended indication, class of
drug, clinical status, region of development, and the product developer/intended marketer
• Pipeline status details preclinical development, Phase I, Phase I/II, Phase II, Phase II/III, Phase
III, and awaiting approval
• Region of development includes the United States, Europe, and Japan

A directory of CNS/Neurology prescription-drug developers and marketers, includes the following
information for each company:
• Mailing address
• General phone, fax, e-mail, and Website
• Year established

A listing of CNS/Neurology medical-device entries, sorted by device class, includes the following details for each product:
• Product code
• Product description
• Registration number
• Company

A directory of medical-device company entries (includes divisions and subsidiaries) that are
associated with CNS/neurology devices, includes the following information for each company:
• FDA Establishment Registration Number
• Mailing address
• General phone, fax, e-mail, and Website
• Year established